Sign In
Buy LMAT
$91.64
+0.0200 (+0.0218%)
At Close: Jun 03, 2026
LeMaitre Vascular Announces Proposed Public Offering of Common Stock
04:02pm, Tuesday, 13'th Jul 2021
BURLINGTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced that it has commenced an u
Should Investors Consider This Expanding Healthcare Business After Its Massive Dividend Hike?
12:14pm, Monday, 12'th Jul 2021
Did LeMaitre Vascular jeopardize its payout with its recent 16% dividend lift?
LeMaitre to Present at the Goldman Sachs Virtual Global Healthcare Conference
09:28am, Wednesday, 09'th Jun 2021
BURLINGTON, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Goldman Sachs 42nd Annual Virtual Glob
LeMaitre Regains Five CE Marks
01:47pm, Tuesday, 25'th May 2021
BURLINGTON, Mass., May 25, 2021 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today announced that it received CE marks under the European Medical
LeMaitre to Present at the Jefferies Virtual Healthcare Conference
05:53pm, Thursday, 20'th May 2021
BURLINGTON, Mass., May 20, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Jefferies Virtual Healthca
LeMaitre Vascular: Balance Sheet Expansion Adds ~$2 Per Share Value To Date
11:01am, Friday, 14'th May 2021
LeMaitre Vascular: Balance Sheet Expansion Adds ~$2 Per Share Value To Date
LeMaitre Vascular (LMAT) Recently Broke Out Above the 20-Day Moving Average
10:31am, Thursday, 06'th May 2021
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
LeMaitre Vascular's (LMAT) CEO George LeMaitre on Q1 2021 Results - Earnings Call Transcript
02:05am, Sunday, 02'nd May 2021
LeMaitre Vascular's (LMAT) CEO George LeMaitre on Q1 2021 Results - Earnings Call Transcript
Recap: LeMaitre Vascular Q1 Earnings
05:14pm, Thursday, 29'th Apr 2021
Shares of LeMaitre Vascular (NASDAQ:LMAT) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 75.00% over the past year to $0.28, which b
LeMaitre Q1 2021 Financial Results
04:06pm, Thursday, 29'th Apr 2021
BURLINGTON, Mass., April 29, 2021 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2021 results and announced an $0.11/share quarter
LeMaitre to Present at Upcoming Investor Conferences
04:23pm, Tuesday, 27'th Apr 2021
BURLINGTON, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in May.
Bull Of The Day: LeMatire Vascular (LMAT)
09:47am, Tuesday, 27'th Apr 2021
Bull Of The Day: LeMatire Vascular (LMAT)
LeMaitre Will Announce First Quarter 2021 Earnings Results on April 29, 2021
04:54pm, Wednesday, 14'th Apr 2021
BURLINGTON, Mass., April 14, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2021 financial results on Thursday, April 29, 2021,
4 Critical Care Device Stocks to Deflect the COVID-19 Curveball
09:05am, Friday, 09'th Apr 2021
Cantel (CMD), Hill-Rom (HRC), LeMaitre (LMAT) and Masimo (MASI) can prove to be prudent investment choices in the critical care industry of the MedTech sector.
New Strong Buy Stocks for April 8th
12:52pm, Thursday, 08'th Apr 2021
New Strong Buy Stocks for April 8th
